文献速递骨质疏松与钙磷/甲状旁腺

肠道菌群与骨质疏松的关联由氨基酸代谢介导:大型队列多组学研究

The Association of Gut Microbiota With Osteoporosis Is Mediated by Amino Acid Metabolism: Multiomics in a Large Cohort.
PubMed 文献 · J Clin Endocrinol Metab · 2021-01-01

该研究在1776名社区成人中分析肠道菌群组成与骨密度,并在971名参与者中进一步分析粪便和血清靶向代谢组。结果显示骨质疏松与肠道菌群β多样性、分类和功能组成相关,且酪氨酸、色氨酸代谢及支链氨基酸降解与菌群标志物和骨质疏松显著关联。结论提示肠道菌群失调和氨基酸代谢可能是骨质疏松干预靶点。

要点

  • 骨质疏松与肠道菌群β多样性、分类及功能组成相关。
  • 部分菌属相对丰度与骨质疏松正相关,另一些负相关。
  • 酪氨酸、色氨酸代谢和支链氨基酸降解与菌群及骨质疏松关联。

核心结论

  • 肠道菌群失调和氨基酸代谢可能是骨质疏松的干预靶点。

研究设计与样本

  • 在1776名社区成人中通过16S rRNA分析肠道菌群组成,双能X线吸收法测骨密度。
  • 在971名参与者中进一步分析粪便(15类)和血清(12类)靶向代谢组。

主要发现

  • 骨质疏松与肠道菌群β多样性、分类和功能组成相关。
  • Actinobacillus、Blautia、Oscillospira、Bacteroides和Phascolarctobacterium相对丰度与骨质疏松正相关。
  • Veillonellaceae other、Collinsella和Ruminococcaceae other与骨质疏松存在负相关。
  • 菌群标志物与骨质疏松的关联涉及微生物功能中的肽酶和转录机制水平。
  • 粪便和血清代谢组提示酪氨酸、色氨酸代谢及缬氨酸、亮氨酸和异亮氨酸降解分别与菌群标志物和骨质疏松显著关联。

临床怎么用

  • 可关注肠道菌群失调及氨基酸代谢通路作为骨质疏松风险评估的潜在标志。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Several small studies have suggested that the gut microbiome might influence osteoporosis, but there is little evidence from human metabolomics studies to explain this association. OBJECTIVE: This study examined the association of gut microbiome dysbiosis with osteoporosis and explored the potential pathways through which this association occurs using fecal and serum metabolomics. METHODS: We analyzed the composition of the gut microbiota by 16S rRNA profiling and bone mineral density using dual-energy X-ray absorptiometry in 1776 community-based adults. Targeted metabolomics in feces (15 categories) and serum (12 categories) were further analyzed in 971 participants using ultra-high-performance liquid chromatography coupled to tandem mass spectrometry. RESULTS: This study showed that osteoporosis was related to the beta diversity, taxonomy, and functional composition of the gut microbiota. The relative abundance of Actinobacillus, Blautia, Oscillospira, Bacteroides, and Phascolarctobacterium was positively associated with osteoporosis. However, Veillonellaceae other, Collinsella, and Ruminococcaceae other were inversely associated with the presence of osteoporosis. The association between microbiota biomarkers and osteoporosis was related to levels of peptidases and transcription machinery in microbial function. Fecal and serum metabolomics analyses suggested that tyrosine and tryptophan metabolism and valine, leucine, and isoleucine degradation were significantly linked to the identified microbiota biomarkers and to osteoporosis, respectively. CONCLUSION: This large population-based study provided robust evidence connecting gut dysbiosis, fecal metabolomics, and serum metabolomics with osteoporosis. Our results suggest that gut dysbiosis and amino acid metabolism could be targets for intervention in osteoporosis.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Ling CW, Miao Z, Xiao ML, et al. The Association of Gut Microbiota With Osteoporosis Is Mediated by Amino Acid Metabolism: Multiomics in a Large Cohort. J Clin Endocrinol Metab. 2021. PMID: 34214160. doi:10.1210/clinem/dgab492

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。